
Advanced Biomed fell 73.1% from $8.26 to $2.22, behind the S&P 500's +11.2%. Its worst day was Jul 27 (−24.3%), and its low came Nov 5 at $1.90.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.40 was reported on $0.00 revenue.
−8.7% · S&P 500 −1.5%
EPS of $6.40 was reported on $0.00 revenue.
Story events cover the past 12 months · Times ET
0.0% · S&P 500 +0.2%
Advanced Biomed shares rose 46.8%, while the S&P 500 rose 0.0%.
+46.8% · S&P 500 0.0%
EPS of $-0.38 was reported on $0.00 revenue.
−0.7% · S&P 500 −1.2%
Advanced Biomed shares rose 28.1%, while the S&P 500 rose 0.2%.
+28.1% · S&P 500 +0.2%
Advanced Biomed closed at its highest level of the year, 129.8% above where the year started.
+13.1% · S&P 500 +0.1%
EPS of $0.12 was reported on $127,637.00 revenue.
−0.4% · S&P 500 −1.1%
Advanced Biomed closed at its lowest level of the year, 77.0% below where the year started.
−9.5% · S&P 500 −4.4%
EPS of $-0.60 was reported on $0.00 revenue.
−23.6% · S&P 500 −0.4%
Where it ended: a close of $2.22 on Nov 16, 2026. Up next: Q2 2027 earnings on Feb 12, 2027.
Nothing in the past 12 months.
All ADVB analyst actionsNothing in the past 12 months.
All ADVB dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ADVB and SPY from Benzinga historical bars. Not investment advice.